← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2010Last known activity
Sep 20, 2025
Timeline
1950s
- Jan 1, 1958
Daewon Pharmaceutical Co., Ltd.— Founded
Drugs by trial phase (34 distinct, 40 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (21 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Arthritis
- Arthritis, Rheumatoid
- Back Pain
- Bronchitis
- Dyslipidemias
- Dysmenorrhea
- Gastritis
- Hypercholesterolemia
- Hypertension
- Infections
- Inflammation
- Kidney Failure, Chronic
- Low Back Pain
- Malnutrition
- Mononeuropathies
- Neuralgia
- Osteoarthritis
- Osteoarthritis, Knee
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Tract Infections
- Toothache
- Wounds and Injuries
Recent trials (40)
- NCT07060209CollaboratorPhase 1Sep 20, 2025
- NCT07032558CollaboratorPhase 1Sep 20, 2025
- NCT07093697Lead sponsorPhase 3Mar 28, 2024
- NCT05365425CollaboratorPhase 4Jun 1, 2023
- NCT07076056Lead sponsorPhase 3Oct 27, 2022
- NCT05970679Lead sponsorPhase 3Aug 17, 2022
- NCT06147908Lead sponsorPhase 1Jul 1, 2022
- NCT05683951Lead sponsorPhase 3Nov 26, 2021
- NCT05163756Lead sponsorPhase 3Nov 25, 2020
- NCT04541134Lead sponsorPhase 3Sep 30, 2020
- NCT05214677Lead sponsorPhase 1Aug 15, 2020
- NCT05214690Lead sponsorPhase 1Aug 13, 2020
- NCT05155072Lead sponsorPhase 1May 15, 2020
- NCT03874247Lead sponsorPhase 3Feb 25, 2019
- NCT04260555Lead sponsorPhase 3Dec 20, 2018
Details
- Founded
- Seoul, KR Jan 1, 1958
- Last known activity
- Sep 20, 2025